Apoptosis in surgically excised choroidal neovascular membranes in age- related macular degeneration

Archives of Ophthalmology

Volumn 116, Issue 2, 1998, Pages 203-209

  Hinton, David R ^a   He, Shikun ^a   Lopez, Pedro F ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Center for Excellence in Eye Care Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; DNA NICK TRANSLATION; DNA STRAND BREAKAGE; FROZEN SECTION; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MYOFIBROBLAST; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; WOUND HEALING;

EID: 0031915307     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.2.203     Document Type: Article

References (52)

1. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
2. Heriot WJ, Henkind P, Belhorn RW, Burns MS. Choroidal neovascularization can digest Bruch's membrane: a prior break is not essential. Ophthalmology. 1984;91:1603-1608.
3. Lopez PF, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112:647-656.
4. Grossniklaus HE, Martinez JA, Brown VB, et al. Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;114:464-472.
5. Das A, Puklin JE, Frank RN, Zhang ML. Ultrastructural immunocytochemistry of subretinal neovascular membranes in age-related macular degeneration. Ophthalmology. 1992;99:1368-1376.
6. Seregard S, Algvere PV, Berglin L. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch Clin Exp Ophthalmol. 1994;232:325-329.
7. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. Transdifferentiated RPE cells are immunoreactive for VEGF in surgically excised ARMD-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996;37:855-868.
8. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995;146:56-66.
9. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol. 1995;147:229-234.
10. Young RW. Cell death during differentiation of the retina in the mouse. J Comp Neurol. 1984;229:362-373.
11. Chang CJ, Lai WW, Edward DP, Tso MOM. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol. 1995;113:880-886.
12. Cook B, Lewis GP, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:990-996.
13. Smith SB, Bora N, McCool D, et al. Photoreceptor cells in the vitiligo mouse die by apoptosis: TRPM-2/clusterin expression is increased in the neural retina and in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1995;36:2193-2201.
14. Chang G-Q, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 1993;11:595-605.
15. Tso MOM, Zhang C, Abler AS, et al. Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats. Invest Ophthalmol Vis Sci. 1994;35:2693-2699.
16. Gregory CY, Bird AC. Cell loss in retinal dystrophies by apoptosis: death by informed consent! Br J Ophthalmol. 1995;79:186-190.
17. Papermaster DS, Windle J. Death at an early age: apoptosis in inherited retinal degenerations. Invest Ophthalmol Vis Sci. 1995;36:977-983.
18. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 1997;115:1031-1035.
19. Hafezi F, Marti A, Munz K, Reme CE. Light-induced apoptosis: differential timing in the retina and pigment epithelium. Exp Eye Res. 1997;64:963-970.
20. Osborne NN, Cazevielle C, Pergande G, Wood JPM. Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine. Invest Ophthalmol Vis Sci. 1997;38:1390-1400.
21. Zhu Z-R, Goodnight R, Nishimura T, Sorgente N, Ogden TE, Ryan SJ. Experimental changes resembling the pathology of drusen in Bruch's membrane in the rabbit. Curr Eye Res. 1988;7:581-592.
22. Burns RP, Feeney-Burns L. Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc. 1980;78:206-225.
23. Bredesen DE. Neural apoptosis. Ann Neurol. 1995;38:839-851.
24. Gavrieli Y, Sherman Y, Benn SS. Identification of programmed cell death in situ via specific labeling of nuclear DMA fragmentation. J Cell Biol. 1992;119:493-501.
25. Schlossman SF, Boumsell L, Gilks W, et al, eds. Leukocyte Typing V. Oxford, England: Oxford University Press; 1994.
26. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75:1169-1178.
27. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 1995;16:569-574.
28. Nishimura T, Akiyama H, Yonehara S, et al. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res. 1995;695:137-145.
29. Wong GHW, Goeddel DV. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol. 1994;152:1751-1755.
30. Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest. 1993;69:415-429.
31. Esser P, Heimann K, Abts H, Fontana A, Weller M. CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1995;213:1026-1034.
32. Lambert HM, Lopez PF, Thomas JW. Surgical removal of submacular neovascular membranes in age-related macular degeneration. Ophthalmol Clin North Am. 1993;6:339-344.
33. Lambert HM, Capone A Jr, Aaberg TM, Sternberg PS Jr, Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;113:257-262.
34. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol. 1991;109:1242-1257.
35. Crompton T, Peitsch MC, MacDonald HR, Tschopp J. Propidium iodide staining correlates with the extent of DNA degradation in isolated nuclei. Biochem Biophys Res Commun. 1992;183:532-535.
36. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA, Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
37. Grierson I, Hiscott P, Hogg P, Robey H, Mazure A, Larkin G. Development, repair and regeneration of the retinal pigment epithelium. Eye. 1994;8:255-262.
38. Cohen JJ. Apoptosis. Immunol Today. 1993;14:126-130.
39. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin 1b-converting enzyme. Am J Pathol. 1995;147:251-266.
40. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
41. Amin R, Puklin JE, Frank RN. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994;35:3178-3188.
42. Reddy VM, Zamora RL, Kaplan HJ. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1995;120:291-301.
43. LaVail MM, Unoki K, Yasamura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A. 1992;89:11249-11253.
44. Alon T, Memo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;10:1024-1028.
45. Barrett G, Bartlett P. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci U S A. 1994;91:6501-6505.
46. Guerrin M, Moukadiri H, Cholett P, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol. 1995;164:385-394.
47. Gabrielian K, Osusky R, Sippy BD, Ryan SJ, Hinton DR. Effect of TGF-β on interferon γ-induced HLA-DR expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1994;35:4253-4259.
48. Streilein JW. Unraveling immune privilege. Science. 1995;270:1158-1159.
49. Freiberg RA, Spencer DM, Choate KA, et al. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J Invest Dermatol. 1997;106:215-219.
50. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med. 1996;2:317-322.
51. Biancone L, De Martino A, Orlandi V, Conaldi PG, Toniolo A, Camussi G. Development of inflammatory angiogensis by local stimulation of Fas in vivo. J Exp Med. 1997;186:147-152.
52. Hunter N, Yan Q, Palvolgyi I, Spee C, Black J, Lopez PF. Histopathologic comparison of the retinal effects of subretinal collagen and gelatin matrix transplantation. Invest Ophthahnol Vis Sci. 1996;37:S99.